+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Autologous Serum Eye Drops Combined With Silicone Hydrogen Lenses for the Treatment of Postinfectious Corneal Persistent Epithelial Defects



Autologous Serum Eye Drops Combined With Silicone Hydrogen Lenses for the Treatment of Postinfectious Corneal Persistent Epithelial Defects



Eye and Contact Lens 43(4): 225-229



To evaluate the clinical effect of combined topical autologous serum eye drops (ASEs) and silicone hydrogel contact lens (CLs) for the treatment of corneal persistent epithelial defects (PEDs) after infectious corneal ulcers. We conducted a retrospective chart review of 12 patients with postinfectious corneal PEDs who were unsuccessfully treated with conventional medical management and were then treated with combined topical 20% (v/v) ASEs and silicone hydrogel CLs from July 1, 2011, to June 30, 2014. The corneal ulcers were all initially managed with antibiotic eye drops until the infiltrates resolved but the lesions failed to epithelialize. The clinical effects of the combined treatment were evaluated. The PEDs healed in all 12 patients within 2 weeks. The combined treatment was associated with an improvement of best-corrected visual acuity (BCVA) at the final 3-month follow-up examination. All patients responded well to the combined treatment and no adverse events were noted in any patient. The combined use of silicone hydrogel CLs and ASEs can successfully treat postinfectious corneal PEDs and prevent continuous corneal melting during acute disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057271573

Download citation: RISBibTeXText

PMID: 26963437

DOI: 10.1097/icl.0000000000000261


Related references

Therapeutic outcomes of combined topical autologous serum eye drops with silicone-hydrogel soft contact lenses in the treatment of corneal persistent epithelial defects: A preliminary study. Contact Lens and Anterior Eye 39(6): 425-430, 2016

Combined application of autologous serum eye drops and silicone hydrogel lenses for the treatment of persistent epithelial defects. Eye and Contact Lens 37(6): 370-373, 2011

Autologous serum eye drops for the treatment of persistent corneal epithelial defects. Journal of the College of Physicians and Surgeons--Pakistan 23(10): 737-739, 2013

Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects. Der Ophthalmologe 101(7): 705-709, 2004

Treatment of Persistent Corneal Epithelial Defects After Vitreoretinal Surgery: Autologous Serum Eye Drops or a Bandage Contact Lens?. Cornea 27(9): 1097-1098, 2008

Combination of serum eye drops with hydrogel bandage contact lenses in the treatment of persistent epithelial defects. Graefe's Archive for Clinical and Experimental Ophthalmology 244(10): 1345-1349, 2006

Treatment of Persistent Corneal Epithelial Defects by Autologous Serum. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 1693, 2002

Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects. Cornea 28(10): 1104-1108, 2009

Autologous Platelet-rich Plasma Eye Drops Accelerate Re-epithelialization of Post-keratoplasty Persistent Corneal Epithelial Defects. Journal of Ophthalmic and Vision Research 14(2): 131-135, 2019

Autologous Serum Eye Drops for Post-Chemical Injuries and Corneal Epithelial Defects. Macedonian Journal of Medical Sciences 6(4): 383-387, 2013

Autologous serum eye drops for treating persistent corneal epithelial defect after vitreoretinal surgery. Cornea 27(9): 1097; Author Reply 1097-8, 2008

Maternal Serum Eye Drops in the Management of Pediatric Persistent Corneal Epithelial Defects: A Case Series. Cornea 37(7): 912-915, 2018

The use of autologous serum tears in persistent corneal epithelial defects. Eye 18(6): 609-614, 2004

Sustained benefits of autologous serum eye drops on self-reported ocular symptoms and vision-related quality of life in Australian patients with dry eye and corneal epithelial defects. Transfusion and Apheresis Science 53(3): 404-411, 2015

Open clinical study of eye drops containing the fibronectin-derived peptide PHSRN for treatment of persistent corneal epithelial defects. Cornea 31(12): 1408-1413, 2012